nilotinib
150 mg/1 · Capsule
By Novadoz Pharmaceuticals LLC
- NDC
- 72205-238
- Route
- Oral
- Therapeutic class
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor , P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 4 BLISTER PACK in 1 CARTON (72205-238-64) / 28 CAPSULE in 1 BLISTER PACKNDC 72205-238-64Available to order
- 28 CAPSULE in 1 BLISTER PACK (72205-238-63)NDC 72205-238-63Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Oncology & Specialty
See all →Verzenio (abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to source
